Page last updated: 2024-11-12

glucagon-like peptide 1 (1-37)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID16131070
MeSH IDM0157235

Synonyms (9)

Synonym
sq6sa9l9xq ,
87805-34-3
glucagon-like peptide i (1-37)
unii-sq6sa9l9xq
glp-i (1-37)
glucagon-like peptide 1 (1-37)
glp-1 (1-37) (human, bovine, guinea pig, mouse, rat) trifluoroacetate salt
DTXSID10236651
glp-1 (1-37)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" GLP-1-related peptides were administered in a dosage of 400 pmol within 10 min into the pancreatic artery during glucose or arginine infusion and the changes in plasma insulin and glucagon in the pancreatic vein were studied."( The structure-function relationship of GLP-1 related peptides in the endocrine function of the canine pancreas.
Kawai, K; Koizumi, F; Ohashi, S; Ohneda, A; Ohneda, K; Ohneda, M; Suzuki, S, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glucagon-like peptide 1 receptorRattus norvegicus (Norway rat)IC50 (µMol)1.00000.00010.50011.0000AID694563
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glucagon-like peptide 1 receptorRattus norvegicus (Norway rat)EC50 (µMol)0.00010.00010.00010.0001AID694565
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlucagon-like peptide 1 receptorRattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID694565Agonist activity at rat GLP1R expressed in HEK293 cells assessed as stimulation of cAMP levels incubated for 6 hrs by multiple response element/cAMP response element (MRE/CRE)-driven reporter gene assay2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor.
AID694563Inhibition of [125I]GLP1 (7-36) amide binding to rat GLP1R expressed in HEK293 cells2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor.
AID694562Inhibition of [125I]Exendin (9-39) binding to rat GLP1R expressed in HEK293 cells2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor.
AID694561Inhibition of [125I]GLP1 (7-36) amide binding to rat GLP1R expressed in HEK293 cells relative to untreated control2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor.
AID694566Agonist activity at human GLP2R expressed in HEK293 cells assessed as stimulation of cAMP levels incubated for 6 hrs by multiple response element/cAMP response element (MRE/CRE)-driven reporter gene assay2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor.
AID1326001Agonist activity at GPR142 in mouse islets assessed as potentiation of glucose-stimulated insulin secretion at 10 nM in presence of 2 to 16 mM glucose2016ACS medicinal chemistry letters, Dec-08, Volume: 7, Issue:12
Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 Diabetes.
AID694564Agonist activity at rat GLP1R expressed in HEK293 cells assessed as stimulation of cAMP levels incubated for 6 hrs by multiple response element/cAMP response element (MRE/CRE)-driven reporter gene assay relative to 10 nM GLP12012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (20.00)18.7374
1990's8 (53.33)18.2507
2000's1 (6.67)29.6817
2010's3 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.23 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]